PacBio将于2022年2月15日公布2021年第四季度和全年财务业绩

MENLO PARK, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2021 financial results on Tuesday, February 15, 2022, at 4:30 pm Eastern Time.

The call will be webcast live and may be accessed at Pacific Biosciences' website at:

Date: Tuesday, February 15, 2022

Time: 4:30pm ET

Listen via Internet:

Toll-free: 888.366.7247

International: 707.287.9330

Conference ID: 3580907

Replay:

About PacBio

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate sequencing platforms. The company's innovative instruments are based on Single Molecule, Real-Time (SMRT^®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio^® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology. For more information please visit and follow @PacBio.

Contacts

Investors:
Todd Friedman
650.521.8450
ir@pacb.com

Media:
Kathy Lynch
pr@pacb.com